Scholarlink

Purpose of Review <p>Recommendations for contraceptive use and pregnancy timing in bariatric surgery patients are established, but there is limited information regarding the reproductive health implications of anti-obesity medications. This review aims to explore the current knowledge on how both anti-obesity surgery and medications impact reproductive health while highlighting gaps that warrant further investigation.</p> Recent Findings <p>It is generally recommended that pregnancy is avoided for 12–18 months after bariatric surgery. Malabsorptive procedures reduce the effectiveness of oral contraceptives. There are limited studies on the safety of anti-obesity medications in pregnancy. In addition, anti-obesity medications may interact with contraceptives, requiring nuanced contraceptive counseling.</p> Summary <p>Obesity treatments have the potential to improve ovulatory function and pregnancy outcomes in women of reproductive age. Current guidelines recommend delaying pregnancy immediately after bariatric surgery. In addition, after malabsorptive surgeries, oral contraceptives may be less effective and so an alternative form of contraception is recommended. Current guidelines also recommend avoiding pregnancy while on anti-obesity medications. However, there are limited data regarding specific effects of anti-obesity medication on pregnancy or potential drug-drug interactions with oral contraceptives.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Obesity Management: Implications for Contraceptive Counseling and Reproductive Health

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月20日

查看全文
  • Valerie Palmer,
  • Eduardo Grunvald,
  • Deepa Sannidhi,
  • Sheila K. Mody

摘要

Purpose of Review

Recommendations for contraceptive use and pregnancy timing in bariatric surgery patients are established, but there is limited information regarding the reproductive health implications of anti-obesity medications. This review aims to explore the current knowledge on how both anti-obesity surgery and medications impact reproductive health while highlighting gaps that warrant further investigation.

Recent Findings

It is generally recommended that pregnancy is avoided for 12–18 months after bariatric surgery. Malabsorptive procedures reduce the effectiveness of oral contraceptives. There are limited studies on the safety of anti-obesity medications in pregnancy. In addition, anti-obesity medications may interact with contraceptives, requiring nuanced contraceptive counseling.

Summary

Obesity treatments have the potential to improve ovulatory function and pregnancy outcomes in women of reproductive age. Current guidelines recommend delaying pregnancy immediately after bariatric surgery. In addition, after malabsorptive surgeries, oral contraceptives may be less effective and so an alternative form of contraception is recommended. Current guidelines also recommend avoiding pregnancy while on anti-obesity medications. However, there are limited data regarding specific effects of anti-obesity medication on pregnancy or potential drug-drug interactions with oral contraceptives.